Abstract
赵蓓蕾,印洁,夏锡荣,施毅,穆守位,郑雷.南京地区组织胞浆菌感染的流行病学调查[J].Chinese journal of Epidemiology,1998,19(4):215-217
南京地区组织胞浆菌感染的流行病学调查
Investigation on the Epidemiology of Histoplasma capsulatum Infection in Nanjing District
Received:April 01, 1998  Revised:April 29, 1998
DOI:
KeyWord: 组织胞浆菌  组织胞浆菌素  皮肤试验
English Key Word: Histoplasma capsulatum  Histoplasmin  Skin test
FundProject:
Author NameAffiliation
Zhao Beilei Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Command, Nanjing 210002 
Yin Jie Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Command, Nanjing 210002 
Xia Xirong Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Command, Nanjing 210002 
Shi Yi Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Command, Nanjing 210002 
Mu Shouwei 安徽省砀山县医院 
Zheng Lei 南京陆军指挥学院医院 
Hits: 3195
Download times: 1172
Abstract:
      用组织胞浆菌素(Histolyn-CYL, ALK/Berkeley Laboratories, 美国)和PPD在南京市调查了292例当地居民或留居者, 发现组织胞浆菌素皮试49例(16.78%)阳性, 阳性皮肤反应直径为5.0~23.0(9.5±4.2)mm, 其中正常人阳性率为15.10%, 肺部疾病病人阳性率为17.74%;PPD皮试阳性率为56.16%, 阳性反应直径为5~50(14.2±4.7)mm, 其中正常人为59.43%, 肺部疾病病人为54.30%;两种皮试均为阳性者有8.90%, 组织胞浆菌素皮试阳性而PPD皮试阴性者为7.88%。结果表明南京地区存在组织胞浆菌人群感染。
English Abstract:
      Two hundred and ninety - two permanent or temporary residents in Nanjing district were tested with histoplasmin (Histolyn- CYL, ALK/Berkeley Laboratories, USA)and PPD. Forty- nine (16.78 %) subjects reacted to histoplasmin with 5.0 - 23.0(9.5±4.2)mm induration. Postive reaction rate among people without pulmonary diseases (normal group) was 15.10% comparing to 17.74% to patients with pulmonary diseases. Positive reaction to PPD with 5~50(14.2±4.7)mm induration was 56.16 %, with 59.43 % in normal group and 54.30 % in patients with pulmonary diseases while 8.90 % subjects reacted to both histoplasmin and PPD. 7.88 % of the research subjects reacted to hitoplasmin but not to PPD. Result suggested that there was herd infection of Histoplasma capsulatum in Nanjing district.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close